GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients
出版年份 2022 全文链接
标题
GSTP1 c.313A > G mutation is an independent risk factor for neutropenia hematotoxicity induced by anthracycline-/paclitaxel-based chemotherapy in breast cancer patients
作者
关键词
-
出版物
World Journal of Surgical Oncology
Volume 20, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-06-22
DOI
10.1186/s12957-022-02679-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan
- (2022) Shiori Hiramoto et al. PLoS One
- Experience of women with breast cancer undergoing chemotherapy: a systematic review of qualitative research
- (2021) Liping Liu et al. QUALITY OF LIFE RESEARCH
- Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
- (2021) Shan-Shan Yang et al. BMC CANCER
- Prediction and assessment of response to neo‐adjuvant chemotherapy in breast cancer: The responsibilities of breast pathologists
- (2021) Shahla Masood Breast Journal
- An Immune-Associated Genomic Signature Effectively Predicts Pathologic Complete Response to Neoadjuvant Paclitaxel and Anthracycline-Based Chemotherapy in Breast Cancer
- (2021) Changfang Fu et al. Frontiers in Immunology
- Breast Cancer Treatments: Updates and New Challenges
- (2021) Anna Burguin et al. Journal of Personalized Medicine
- Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Drug-related problems and its associated factors among breast cancer patients at the University of Gondar Comprehensive Specialized Hospital, Ethiopia: A hospital-based retrospective cross-sectional study
- (2020) Amsalu Degu et al. JOURNAL OF ONCOLOGY PHARMACY PRACTICE
- Polymorphisms in GSTT1 and GSTM1 genes as possible risk factors for susceptibility to breast cancer development and their influence in chemotherapy response: a systematic review
- (2020) Letícia Madureira Pacholak et al. MOLECULAR BIOLOGY REPORTS
- Selection of Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer: ASCO Guideline Update
- (2020) Neelima Denduluri et al. JOURNAL OF CLINICAL ONCOLOGY
- Acute toxicity and tolerability of anthracycline-based chemotherapy regimens in older versus younger patients with breast cancer: real-world data
- (2020) Ana Raquel Monteiro et al. SUPPORTIVE CARE IN CANCER
- Long non-coding RNAs: from disease code to drug role
- (2020) Yuanyuan Chen et al. Acta Pharmaceutica Sinica B
- Predictive value of clinical toxicities of chemotherapy with fluoropyrimidines and oxaliplatin in colorectal cancer by DPYD and GSTP1 gene polymorphisms
- (2020) Xunwei Deng et al. World Journal of Surgical Oncology
- Seeking for Correlative Genes and Signaling Pathways With Bone Metastasis From Breast Cancer by Integrated Analysis
- (2019) Yu Zhang et al. Frontiers in Oncology
- Survival following radiotherapy in young women with localized early‐stage breast cancer according to molecular subtypes
- (2019) Qi‐Qi Liu et al. Cancer Medicine
- Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
- (2019) Rui-Mei Feng et al. Cancer Communications
- Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
- (2019) Yiran Liang et al. SEMINARS IN CANCER BIOLOGY
- The multifaceted role of glutathione S-transferases in cancer
- (2018) Anupam Chatterjee et al. CANCER LETTERS
- Genetic Risk Factors Associated With Antiemetic Efficacy of Palonosetron, Aprepitant, and Dexamethasone in Japanese Breast Cancer Patients Treated With Anthracycline-based Chemotherapy
- (2018) Satoshi Yokoyama et al. Clinical Breast Cancer
- Molecular Subtypes and Local-Regional Control of Breast Cancer
- (2018) Simona Maria Fragomeni et al. Surgical Oncology Clinics of North America
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Contribution of the GSTP1 c.313A>G variant to hearing loss risk in patients exposed to platin chemotherapy during childhood
- (2018) P. H. P. Liberman et al. Clinical & Translational Oncology
- Glutathione S-transferase π: a potential role in antitumor therapy
- (2018) Shu-Chen Dong et al. Drug Design Development and Therapy
- Risk Factors and Preventions of Breast Cancer
- (2017) Yi-Sheng Sun et al. International Journal of Biological Sciences
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- GSTP1 c.313A>G polymorphism in Russian and Polish athletes
- (2017) Aleksandra Zarebska et al. PHYSIOLOGICAL GENOMICS
- GSTP1 polymorphism predicts treatment outcome and toxicities for breast cancer
- (2017) Jie Ma et al. Oncotarget
- Taxanes in the treatment of breast cancer: Have we better defined their role in older patients? A position paper from a SIOG Task Force
- (2016) L. Biganzoli et al. CANCER TREATMENT REVIEWS
- Advances in Medical Management of Early Stage and Advanced Breast Cancer: 2015
- (2016) Sabrina Witherby et al. SEMINARS IN RADIATION ONCOLOGY
- Clinical implications of the intrinsic molecular subtypes of breast cancer
- (2015) Aleix Prat et al. BREAST
- Comparison of Toxicity Experienced by Older Versus Younger Patients Enrolled in Breast Cancer Clinical Trials
- (2015) Caroline Mariano et al. Clinical Breast Cancer
- Effect of GSTP1 and ABCC4 gene polymorphisms on response and toxicity of cyclophosphamide-epirubicin-5-fluorouracil-based chemotherapy in Bangladeshi breast cancer patients
- (2015) Md. Siddiqul Islam et al. TUMOR BIOLOGY
- Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer
- (2014) Mihoko Sugishita et al. Breast Cancer
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Pharmacogenetic Influence of GST Polymorphisms on Anthracycline-Based Chemotherapy Responses and Toxicity in Breast Cancer Patients: A Multi-Analytical Approach
- (2013) Sonam Tulsyan et al. Molecular Diagnosis & Therapy
- The GSTP1 105Val Allele Increases Breast Cancer Risk and Aggressiveness but Enhances Response to Cyclophosphamide Chemotherapy in North China
- (2013) Jie Ge et al. PLoS One
- Impact of glutathione-S-transferase gene polymorphisms on enzyme activity, lung function and bronchial asthma susceptibility in Egyptian children
- (2012) Rehab A. Karam et al. GENE
- Gene Polymorphisms in Cyclophosphamide Metabolism Pathway,Treatment-Related Toxicity, and Disease-Free Survival in SWOG 8897 Clinical Trial for Breast Cancer
- (2010) S. Yao et al. CLINICAL CANCER RESEARCH
- Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin
- (2008) Christina Peklak-Scott et al. MOLECULAR CANCER THERAPEUTICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started